Becton Dickinson and Co. said Friday it bought molecular diagnostic test maker HandyLab Inc. for $275 million.
The company first announced the acquisition in October.
The company has said it would run tests for infections such as MRSA on a diagnostic test platform made by Ann Arbor, Mich.-based HandyLab. The product will be sold as a new version of Becton Dickinson's BD Max system.
Shares of Becton Dickinson rose 24 cents to close at $73.70.